Related Experiment Video
Updated: Jun 7, 2025
Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
Published on: March 1, 2024
Orofacial Granulomatosis and Crohn's Disease: A Case Series
Siri A Urquhart1, Grace Y Kim2, Katelyn R Anderson2
1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN.
Abstract:
Orofacial granulomatosis (OFG) is a rare syndrome that can occur in association with Crohn's disease (CD). The electronic medical record was searched for "OFG" and "CD." A total of 297 patients were identified, and relevant data were abstracted. Five patients met inclusion criteria. Most (80%) had ileocolonic CD with nonstricturing/nonpenetrating phenotype. The most common treatments included intralesional corticosteroids (4 patients), oral corticosteroids (3 patients), and anti-TNF agents, specifically infliximab (3 patients). Intralesional corticosteroid administration was followed by partial response in 3 patients, but recurrences were common following initial injection. One patient had no response to topical or oral corticosteroids, antihistamines, or oral antibiotics, but partial response to intralesional corticosteroids and infliximab. None of the patients had complete response to any therapies directed at this condition. OFG may be characterized by partial response, often requiring long-term therapy. Additional investigations into novel treatments may improve future clinical outcomes.
Insights
Orofacial granulomatosis (OFG) associated with Crohn's disease (CD) often shows partial treatment response. Long-term management and novel therapies are crucial for improving outcomes in these rare cases.
Area of Science:
- Gastroenterology
- Dermatology
- Immunology
Background:
- Orofacial granulomatosis (OFG) is a rare condition.
- OFG can be associated with Crohn's disease (CD).
Observation:
- A study reviewed 297 patients with OFG and CD.
- Five patients met inclusion criteria for detailed analysis.
- Most patients had ileocolonic CD with a nonstricturing/nonpenetrating phenotype.
Findings:
- Common treatments included intralesional corticosteroids, oral corticosteroids, and anti-TNF agents like infliximab.
- Partial response was observed with intralesional corticosteroids, but recurrences were frequent.
- No patient achieved a complete response to any single therapy.
Implications:
- OFG management in CD patients often requires long-term therapy with partial response.
- Further research into novel treatments is needed to enhance clinical outcomes.
- Understanding the interplay between OFG and CD is critical for effective patient care.
Related Concept Videos
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents